This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Debruyne, J. Articles by Leroux-Roels, G. Search for Related Content PubMed PubMed Citation Articles by Debruyne, J. Articles by Leroux-Roels, G. Social Bookmarking                         What's this?

Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?

Department of Neurology, University Hospital Gent, De Pintelaan 185, B-9000 Gent, Belgium

Jan Philippé

Laboratory of Clinical Chemistry, Microbiology and Immunology, University Hospital Gent, De Pintelaan 185, B-9000 Gent, Belgium

Jacques Dereuck

Department of Neurology, University Hospital Gent, De Pintelaan 185, B-9000 Gent, Belgium

Annick Willems

Laboratory of Clinical Chemistry, Microbiology and Immunology, University Hospital Gent, De Pintelaan 185, B-9000 Gent, Belgium

Geert Leroux-Roels

Laboratory of Clinical Chemistry, Microbiology and Immunology, University Hospital Gent, De Pintelaan 185, B-9000 Gent, Belgium

In vitro tumor necrosis factor-a (TNF-a), interferon-g (IFN-g) and interleukin-2 (IL-2) production, serum neopterin levels, and T-lymphocyte subpopulations were determined on a monthly basis in 22 MS patients. We found increased in vitro TNF-a production from 4 weeks on prior to the day of an exacerbation. There was a significant correlation with in vitro IFN-g release, the absolute blood monocyte count and the serum neopterin levels, suggesting that monocytes stimulated by IFN-g play an important role in the TNF-a production. Serial analysis of in vitro TNF-a production proved to be a helpful tool in predicting relapses in MS patients. Furthermore, elevated levels of IFN-g and IL-2 after stimulation with OKT3 during exacerbations were demonstrated. These increases were not reflected by changes in T-lymphocyte subpopulations. However, significant differences in T-cell subsets were observed between controls and relapsing progressive patients.

Key Words: multiple sclerosis • interferon- • tumor necrosis factor- • interleukin-2 • neopterin • T-lymphocyte subpopulations

Multiple Sclerosis, Vol. 4, No. 3, 193-197 (1998)
DOI: 10.1177/135245859800400320


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. L. Sweeten, D. J. Posey, and C. J. McDougle High Blood Monocyte Counts and Neopterin Levels in Children With Autistic Disorder Am J Psychiatry, September 1, 2003; 160(9): 1691 - 1693. [Abstract] [Full Text] [PDF]

				V Ozenci, M Kouwenhoven, and H Link Cytokines in multiple sclerosis: methodological aspects and pathogenic implications Multiple Sclerosis, October 1, 2002; 8(5): 396 - 404. [Abstract] [PDF]

				S Skurkovich, A Boiko, I Beliaeva, A Buglak, T Alekseeva, N Smirnova, O Kulakova, V Tchechonin, O Gurova, T Deomina, et al. Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis Multiple Sclerosis, October 1, 2001; 7(5): 277 - 284. [Abstract] [PDF]